Pyc Therapeutics Ltd has released a press release.
Flagship Program - Successful Animal Models
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- First Competitive Read Out - Peptide Vaccine
- Dec 2018 Operational Update and App4C
- CEO letter and Operational Update
- In Vivo Success - peptide vaccine (Amended Graphics)
- In vivo success - peptide vaccine in Herpes Simplex Virus
Later from PYC Therapeutics
- Collaboration Agreement - siRNA delivery
- March 2019 Quarterly Operational Update and App4C
- Break Through Animal Model Results
- Animal Models - 400% Outperformance of Gold Standard
- Operational Update and Appendix 4C
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics